28 May 2024
Infrastructure India plc
("IIP" or the "Company" or, together with its subsidiaries, the "Group")
Termination of the Sale of Indian Energy Limited
Infrastructure India plc, an AIM quoted infrastructure fund investing directly into assets in India, announces that on 27 May 2024, it terminated the conditional agreement ("SPA") for the disposal of Indian Energy (Mauritius) Limited ("IEL") to FA Power Renewables Private Limited ("FA Power"), announced on 4 April 2023 and in subsequent updates, due to breach of contract by FA Power.
FA Power has breached the SPA by failing to pay the full consideration for IEL. IIP has, in good faith, endeavoured to close the transaction at FA Power's request, as long as the original terms of the SPA were met or protected. This has not been achieved.
IEL is an independent power producer that owns and operates wind farms at two sites in the states of Karnataka and Tamil Nadu, with 41.3MW of installed capacity. IEL is in discussions with other buyers and the Company will make an announcement, as appropriate, in due course.
IEL was valued at USD 4.3 million in IIP's unaudited interim results for the period ended 30 September 2023.
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).
- Ends -
Enquiries:
|
Infrastructure India plc Sonny Lulla
|
Via Novella |
|
| |
| Strand Hanson Limited Nominated Adviser Richard Johnson / James Dance
| +44 (0) 20 7409 3494 |
|
Singer Capital Markets Broker James Maxwell - Corporate Finance James Waterlow - Investment Fund Sales
|
+44 (0) 20 7496 3000 |
| Novella Financial PR Tim Robertson / Safia Colebrook | +44 (0) 20 3151 7008 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.